EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $519,048 | -16.5% | 26,700 | +21.9% | 0.01% | -16.7% |
| Q1 2023 | $621,303 | -2.9% | 21,900 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $640,137 | +41.7% | 21,900 | +28.1% | 0.01% | +40.0% |
| Q3 2022 | $451,782 | +89.8% | 17,100 | +256.2% | 0.01% | +150.0% |
| Q1 2022 | $238,000 | -2.5% | 4,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $244,000 | -77.9% | 4,800 | -78.1% | 0.00% | -84.6% |
| Q1 2019 | $1,106,000 | +29.5% | 21,900 | +3.3% | 0.01% | +8.3% |
| Q4 2018 | $854,000 | +3.5% | 21,200 | +78.2% | 0.01% | +20.0% |
| Q3 2018 | $825,000 | +4.8% | 11,900 | +14.4% | 0.01% | 0.0% |
| Q2 2018 | $787,000 | +24.5% | 10,400 | -13.3% | 0.01% | +25.0% |
| Q1 2018 | $632,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |